Aquestive Therapeutics, Inc. AQST

4.68 (0.14) (2.90%) as of 25 Sep
Market cap
$605.0M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
121.17 71.55 23.87 27.27 28.02 31.81 49.33 60.60 17.38 9.21
Receivables
17.76 7.34 8.47 4.70 12.12 6.96 13.13 6.48 6.18 10.82
Inventory
6.17 6.04 6.77 5.78 4.04 2.46 2.86 5.44 4.01 2.89
Other current assets
— — — — — — — — — 0.42
Total current assets
149.27 88.22 40.97 39.89 47.26 44.63 68.31 74.20 28.16 23.33
Property, Plant, Equpment (Net)
3.89 3.80 4.18 4.09 5.06 6.87 9.73 12.21 13.46 15.12
Goodwill and Intangible Assets (Total)
— — 1.28 1.44 0.05 0.10 0.15 0.44 0.25 0.31
Long-term assets (Other)
2.64 4.22 5.44 6.45 6.90 7.84 0.29 0.24 1.24 0.63
Total non-current assets
11.16 13.20 16.45 17.18 14.73 18.26 10.17 12.65 14.95 —
Total Assets
160.43 101.42 57.42 57.07 61.99 62.88 78.48 86.85 43.12 39.39
Notes Payable
— — 0.02 18.70 — — — — — —
Accounts Payable
29.86 10.29 8.93 9.95 8.31 7.09 12.27 20.44 9.60 6.64
Accrued Expenses
5.03 5.91 6.50 7.97 8.74 8.57 5.48 7.20 4.40 —
Current Revenue (Deferred)
1.09 1.05 1.55 1.51 0.77 0.69 0.81 0.72 1.35 —
Other current liabilities
1.00 1.09 0.92 1.15 1.23 1.45 6.28 7.92 5.75 4.17
Total current liabilities
47.61 18.87 18.31 39.53 21.96 21.10 18.56 32.95 15.35 10.81
Long Term Debt (Total)
27.52 32.50 27.51 33.45 51.55 34.33 60.34 42.60 45.51 38.65
Non-current Revenue (Deferred)
19.39 20.01 32.35 31.42 7.12 3.63 4.35 — — —
Non-current Liabilities (Other)
95.23 85.24 80.35 66.15 61.54 49.47 1.36 1.22 8.75 7.51
Total non-current liabilities
146.48 142.72 145.60 136.10 122.16 90.28 66.05 43.82 54.26 —
Total liabilities
194.09 161.58 163.91 175.62 144.13 111.38 84.60 76.77 69.61 56.97
Additional Paid In Capital
413.21 302.97 212.52 192.60 174.62 137.73 124.32 71.43 0.00 —
Preferred Stock (Total)
— — — — — — — — 80.87 —
Common Stock (Net)
0.12 0.09 0.07 0.06 0.04 0.04 0.03 0.03 12.73 11.24
Retained Earnings
(447.00) (363.21) (319.08) (311.21) (256.80) (186.26) (130.47) (61.38) (120.09) (108.67)
Common Equity (Total)
(33.66) (60.16) (106.49) (118.55) (82.13) (48.50) (6.12) 10.08 (107.37) (95.97)
Shareholders Equity (Total)
(33.66) (60.16) (106.49) (118.55) (82.13) (48.50) (6.12) 10.08 (26.49) (17.58)
Shareholders Equity and Liabilities (Total)
160.43 101.42 57.42 57.07 61.99 62.88 78.48 86.85 43.12 —
Shares (Common)
122.04 91.41 68.53 54.83 41.23 34.57 33.56 24.96 121.23 —
Shares (Preferred)
— — — — — — — — 38.41 —
Shareholders Equity (Tangible)
(33.66) (60.16) (107.76) (119.99) (82.18) (48.60) (6.27) 9.64 (26.75) —
Net Debt
(93.65) (39.05) 3.64 6.18 23.53 2.52 11.01 (18.00) 28.13 29.44
Total Debt
27.52 32.50 27.51 33.45 51.55 34.33 60.34 42.60 45.51 38.65

Fold the line items

In millions of $ except per-share values · columns are period end dates